PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-77

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,914 Posts.
    lightbulb Created with Sketch. 1287
    FOMO may set in given it could replace current standard of care.

    Retreatment at 12 months is likely once we see this clinically tested

    Retreated patients will in all likelihood provide >$ than initial (new) treated patients within 5 years of release.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.